- Home
- BGLC vs PMAX Comparison
BGLC vs PMAX Comparison
Compare BGLC & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- PMAX
- Stock Information
- Founded
- BGLC 2017
- PMAX 2019
- Country
- BGLC Malaysia
- PMAX Hong Kong
- Employees
- BGLC N/A
- PMAX N/A
- Industry
- BGLC Medical Specialities
- PMAX
- Sector
- BGLC Health Care
- PMAX
- Exchange
- BGLC Nasdaq
- PMAX Nasdaq
- Market Cap
- BGLC 5.8M
- PMAX 6.6M
- IPO Year
- BGLC N/A
- PMAX 2024
- Fundamental
- Price
- BGLC $0.29
- PMAX $0.44
- Analyst Decision
- BGLC
- PMAX
- Analyst Count
- BGLC 0
- PMAX 0
- Target Price
- BGLC N/A
- PMAX N/A
- AVG Volume (30 Days)
- BGLC 1.4M
- PMAX 3.7M
- Earning Date
- BGLC 05-14-2025
- PMAX 04-15-2025
- Dividend Yield
- BGLC N/A
- PMAX N/A
- EPS Growth
- BGLC N/A
- PMAX N/A
- EPS
- BGLC N/A
- PMAX 0.04
- Revenue
- BGLC $9,259,858.00
- PMAX $5,970,263.00
- Revenue This Year
- BGLC N/A
- PMAX N/A
- Revenue Next Year
- BGLC N/A
- PMAX N/A
- P/E Ratio
- BGLC N/A
- PMAX $10.40
- Revenue Growth
- BGLC N/A
- PMAX 30.05
- 52 Week Low
- BGLC $0.21
- PMAX $0.28
- 52 Week High
- BGLC $1.00
- PMAX $4.70
- Technical
- Relative Strength Index (RSI)
- BGLC 45.41
- PMAX N/A
- Support Level
- BGLC $0.23
- PMAX N/A
- Resistance Level
- BGLC $0.29
- PMAX N/A
- Average True Range (ATR)
- BGLC 0.03
- PMAX 0.00
- MACD
- BGLC -0.00
- PMAX 0.00
- Stochastic Oscillator
- BGLC 47.67
- PMAX 0.00
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.